Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases

发表于 2026-7-7 10:56:17

期刊：Journal of Medicinal Chemistry

文献作者：Xi-Wei Wu; Zhao-Min Chen; Cui Gao; Mi Tian; Xi-Le Liu; Hui Wang; Hai-Jie Chen; Han-Xiong Li; Wen-Qian Yang; Lin-Kun An

出版日期：--

DOI号：10.1021/acs.jmedchem.6c00828

下载链接：https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6c00828

文献链接：https://doi.org/10.1021/acs.jmedchem.6c00828

当前文献来源于 American Chemical Society (ACS)。

备注信息：

发表于 2026-7-7 10:56:18

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ACS] Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ACS] Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases 一键复制